The comparable hyperkeratosis rates observed with both TKIs imply a class effect potentially mediated through EGFR or PDGFR pathway inhibition, which may disrupt keratinocyte proliferation and differentiation homeostasis (Malovitski et al., 2023). The gene discussed is EGFR; the disease is Hyperkeratosis.